U.S. market Closed. Opens in 1 day 6 hours 15 minutes

JAGX | Jaguar Health, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue9.76M11.96M4.33M9.38M5.78M4.42M4.36M141.52K258.38KN/A
Cost of Revenue2.04M2.02M2.33M3.28M3.82M2.77M880.40K51.97K123.46KN/A
Gross Profit7.72M9.94M2.00M6.11M1.96M1.65M3.48M89.56K134.92KN/A
Operating Expenses42.02M44.35M41.08M27.41M26.91M27.26M18.60M13.68M12.58M8.32M
Selling, General & Admin23.05M26.70M26.00M21.00M20.44M22.11M14.33M6.47M6.10M4.10M
Research & Development18.60M17.65M15.08M6.41M5.82M5.15M4.27M7.21M6.48M4.22M
Other Operating Expenses371.00K950.00K-765.00K190.00K648.80K315.69K88.55K-11.05K-27.28KN/A
Operating Income-34.29M-34.41M-39.07M-21.30M-24.95M-30.82M-34.25M-13.59M-12.45M-8.32M
Other Expenses / Income-7.61M-13.98M-11.89M-7.16M-9.58M-1.32M-902.80K-1.15M-3.85M-293.91K
Before Tax Income-41.90M-48.40M-52.60M-33.81M-38.53M-32.15M-35.15M-14.73M-16.29M-8.61M
Income Tax ExpensesN/A-941.00K7.65M2.98M10.00K-1.28M-13.18M1.14M3.82M345.34K
Net Income-41.30M-47.45M-60.25M-36.79M-38.54M-32.15M-21.97M-14.73M-16.29M-8.61M
Interest Expenses6.38M12.72M8.42M2.79M5.73M2.63M1.21M985.55K3.32MN/A
Basic Shares Outstanding384.47K1.31M596.15K171.75K22.07K2.07K806.0059.0034.0042.00
Diluted Shares Outstanding384.47K1.31M596.15K171.75K22.07K2.07K806.0059.0034.0042.00
EBITDA-33.13M-33.38M-42.35M-28.74M-30.87M-27.77M-11.13M-13.70M-12.97M-8.37M
EBITDA Margin-339.42%-279.19%-976.98%-306.20%-534.53%-628.83%-255.23%-9,680.93%-5,019.37%0.00%
EBIT-34.92M-35.67M-44.18M-31.02M-32.80M-30.79M-33.94M-12.61M-9.16M-8.26M
EBIT Margin-357.73%-298.36%-1,019.12%-330.50%-567.92%-697.28%-778.23%-8,911.26%-3,543.36%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙